Candel Therapeutics(CADL)
NEEDHAM, MA
Biotechnology3 H-1B visas (FY2023)Focus: Oncolytic Viral Immunotherapies for Cancer
Candel Therapeutics is a life sciences company focused on Oncolytic Viral Immunotherapies for Cancer.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
CAN-2409 + valacyclovir
Lung CancerClinical Trials (1)
NCT03131037Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Phase 1rQNestin
Malignant Glioma of BrainClinical Trials (1)
NCT03152318A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
Phase 1Phase 1
Clinical Trials (1)
NCT00638612AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
Phase 1AdV-tk
Glioma, MalignantAdV-tk
Malignant GliomaClinical Trials (1)
NCT00634231A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase 1AdV-tk
Malignant GliomaClinical Trials (1)
NCT00751270Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
Phase 1AdV-tk + valacyclovir
Malignant Pleural EffusionClinical Trials (1)
NCT01997190Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Phase 1Aglatimagene besadenovec
Borderline Resectable Pancreatic AdenocarcinomaClinical Trials (1)
NCT02446093Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Phase 2aglatimagene besadenovec + valacyclovir
Prostate Cancer Patients Treated by RadiotherapyClinical Trials (1)
NCT07332000A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2aglatimagene besadenovec
Prostate CancerClinical Trials (1)
NCT02768363Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Phase 2CAN-2409
Malignant GliomaClinical Trials (1)
NCT00589875Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
Phase 2Aglatimagene besadenovec
Non Small Cell Lung CancerClinical Trials (1)
NCT04495153CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Phase 2Aglatimagene besadenovec + valacyclovir
Prostate CancerClinical Trials (1)
NCT01436968Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 12 clinical trials
H-1B (2023): 3 approvals
SEC Filings: 2 available
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub